{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:24:37Z","timestamp":1779254677013,"version":"3.51.4"},"reference-count":19,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["Non-specific funding for research in general"],"award-info":[{"award-number":["Non-specific funding for research in general"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To describe the anatomical and functional outcomes of the novel LVP keratoprosthesis (Kpro), developed as an alternative to the modified osteo-odonto keratoprosthesis (MOOKP), in eyes with end-stage corneal blindness where conventional corneal surgeries are contraindicated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective case series included 58 eyes of 56 patients (12 children and 44 adults) with severe bilateral keratopathy and completely dry, dermalised ocular surfaces who underwent unilateral LVP Kpro implantation from 2012 to 2016. In this two-stage procedure, an ocular surface labial mucous membrane grafting was performed, followed for 3\u2009months by the implantation of the device under the engrafted mucosal flap. The primary outcome measures were anatomical retention rate and improvement in best corrected visual acuity (BCVA). The secondary outcome measure was rate of occurrence of complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean postoperative follow-up was 2.5\u00b11.1 years. Kaplan-Meier survival analysis showed an anatomical retention rate of 90.8%\u00b13.9% at 1\u2009year, 80%\u00b15.7% at 2\u2009years and 76.6%\u00b16.5% at 3\u20135 years. The survival rates were comparable in children and adults (91% vs 72% at 5 years, p=0.258). About 61.5% of eyes maintained 20\/400 or better vision and median BCVA improved from perception of light to 20\/70 at 1\u2009year postoperatively (p&lt;0.0001). Complications like retroprosthetic membrane formation, glaucoma, vitritis, endophthalmitis and panophthalmitis occurred in 43%, 26%, 22%, 12% and 3% of the eyes, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The LVP Kpro is an effective procedure for the treatment of end-stage corneal blindness in completely dry eyes. The LVP Kpro can be particularly useful in situations where the MOOKP is contraindicated or difficult to perform.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311649","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T16:15:20Z","timestamp":1528733720000},"page":"592-598","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["LVP keratoprosthesis: anatomical and functional outcomes in bilateral end-stage corneal blindness"],"prefix":"10.1136","volume":"103","author":[{"given":"Sayan","family":"Basu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Serna-Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil","family":"Bhalekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupesh","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virender","family":"Sangwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"2022050605200919000_103.5.592.1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/OPTH.S27083","article-title":"Keratoprostheses for corneal blindness: a review of contemporary devices","volume":"9","author":"Avadhanam","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"2022050605200919000_103.5.592.2","doi-asserted-by":"publisher","DOI":"10.1586\/17469899.1.1.41"},{"key":"2022050605200919000_103.5.592.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.015"},{"key":"2022050605200919000_103.5.592.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.015"},{"key":"2022050605200919000_103.5.592.5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/112067219600600205","article-title":"The Dacron felt colonisable keratoprosthesis: after 15 years","volume":"2","author":"Pintucci","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"2022050605200919000_103.5.592.6","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.25828"},{"key":"2022050605200919000_103.5.592.7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00417-008-0850-3","article-title":"Long-term functional and anatomical results of osteo- and osteoodonto-keratoprosthesis","volume":"246","author":"Michael","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022050605200919000_103.5.592.8","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318215207c"},{"key":"2022050605200919000_103.5.592.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.11.002"},{"key":"2022050605200919000_103.5.592.10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ophtha.2016.07.011","article-title":"Long-term visual outcomes and complications of boston keratoprosthesis type II implantation","volume":"124","author":"Lee","year":"2017","journal-title":"Ophthalmology"},{"key":"2022050605200919000_103.5.592.11","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.10.1319"},{"key":"2022050605200919000_103.5.592.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.06.012"},{"key":"2022050605200919000_103.5.592.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2012.01.003"},{"key":"2022050605200919000_103.5.592.14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0301-4738.94060","article-title":"Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency","volume":"60","author":"Basu","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"2022050605200919000_103.5.592.15","doi-asserted-by":"crossref","unstructured":"Basu S , Sureka S , Shukla R , et al . Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome. BMJ Case Rep 2014;2014:bcr2013202756.doi:10.1136\/bcr-2013-202756","DOI":"10.1136\/bcr-2013-202756"},{"key":"2022050605200919000_103.5.592.16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00003226-200310000-00001","article-title":"AlphaCor cases: comparative outcomes","volume":"22","author":"Hicks","year":"2003","journal-title":"Cornea"},{"key":"2022050605200919000_103.5.592.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2004.01.014"},{"key":"2022050605200919000_103.5.592.18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/ICO.0b013e3181ca31fc","article-title":"Modified osteo-odonto keratoprosthesis--the Indian experience--results of the first 50 cases","volume":"29","author":"Iyer","year":"2010","journal-title":"Cornea"},{"key":"2022050605200919000_103.5.592.19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jtos.2016.02.006","article-title":"Surgical management of bilateral limbal stem cell deficiency","volume":"14","author":"Vazirani","year":"2016","journal-title":"Ocul Surf"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T12:21:40Z","timestamp":1651839700000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,4,17]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311649"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311649","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]}}}